Cost Analysis of Several Treatment Sequences Used for The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal: The Case for Cladribine Tablets

Relapsing Remitting Multiple Sclerosis ◽

Treatment Sequences

Cost-Analysis of Relapsing-Remitting Multiple Sclerosis in Italy after the???Introduction of New Disease-Modifying Agents

Clinical Drug Investigation ◽

10.2165/00044011-200424070-00004 ◽

2004 ◽

Vol 24 (7) ◽

pp. 409-420 ◽

Cited By ~ 18

Author(s):

Pierluigi Russo ◽

Alessandro Capone ◽

Andrea Paolillo ◽

Francesco Macchia ◽

Federica Ranzato ◽

...

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

New Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Disease Modifying Agents ◽

Cost analysis of a relapse-free patient in relapsing-remitting multiple sclerosis

10.26226/morressier.59a3e8b5d462b8028d894644 ◽

2017 ◽

Author(s):

Lucía Romero-Pinel

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Relapsing Remitting ◽

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain

Health Economics Review ◽

10.1186/2191-1991-3-13 ◽

2013 ◽

Vol 3 (1) ◽

Cited By ~ 4

Author(s):

Rainel Sanchez-de la Rosa ◽

Eliazar Sabater ◽

Miguel A Casado

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Glatiramer Acetate ◽

Relapsing Remitting ◽

PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

Value in Health ◽

10.1016/j.jval.2012.08.1954 ◽

2012 ◽

Vol 15 (7) ◽

pp. A551

Author(s):

R. Sánchez-de la Rosa ◽

E. Sabater ◽

M.A. Casado

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Glatiramer Acetate ◽

Relapsing Remitting ◽

PND36 Real-World Evaluation of Patients Affected By Multiple Sclerosis (MS), Relapsing-Remitting Multiple Sclerosis (RRMS) or Secondary Progressive Multiple Sclerosis (SPMS) in Italy: Prevalence, Pharmaco-Utilization and Cost Analysis

Value in Health ◽

10.1016/j.jval.2020.08.1361 ◽

2020 ◽

Vol 23 ◽

pp. S629

Author(s):

V. Perrone ◽

E. Giacomini ◽

D. Alessandrini ◽

S. Migliaccio ◽

D. Ritrovato ◽

...

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Real World ◽

Progressive Multiple Sclerosis ◽

Secondary Progressive Multiple Sclerosis ◽

Secondary Progressive ◽

Relapsing Remitting ◽

Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain

Value in Health ◽

10.1016/j.jval.2014.08.876 ◽

2014 ◽

Vol 17 (7) ◽

pp. A394 ◽

Cited By ~ 1

Author(s):

R. Sanchez de la Rosa ◽

Bujalance L. Garcia ◽

J. Meca Lallana

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Glatiramer Acetate ◽

Relapsing Remitting ◽

Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study

Health Economics Review ◽

10.1186/s13561-015-0066-2 ◽

2015 ◽

Vol 5 (1) ◽

Cited By ~ 2

Author(s):

Rainel Sánchez-de la Rosa ◽

Laura García-Bujalance ◽

José Meca-Lallana

Keyword(s):

Multiple Sclerosis ◽

Cost Analysis ◽

Glatiramer Acetate ◽

Interferon Β ◽

Relapsing Remitting ◽

How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

Value in Health ◽

10.1016/j.jval.2017.08.2107 ◽

2017 ◽

Vol 20 (9) ◽

pp. A752

Author(s):

C Cartier-Bechu ◽

M Sivignon ◽

A Petitjean ◽

S Roze ◽

J Pinguet ◽

...

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Economic Evaluation ◽

Health Authority ◽

Health Economic Evaluation ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Treatment Sequences

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2012.04.028 ◽

2012 ◽

Vol 2012 ◽

pp. 70-71

Author(s):

A. Minagar

Keyword(s):

Multiple Sclerosis ◽

Randomized Trial ◽

High Dose ◽

Vitamin D2 ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

High Dose Vitamin

Interferon beta-1b therapy in relapsing-remitting multiple sclerosis: Study design and preliminary results

Electroencephalography and Clinical Neurophysiology ◽

10.1016/s0013-4694(97)88414-7 ◽

1997 ◽

Vol 103 (1) ◽

pp. 99

Author(s):

G Salemi

Keyword(s):

Multiple Sclerosis ◽

Study Design ◽

Interferon Beta ◽

Preliminary Results ◽

Relapsing Remitting ◽